Paul E Croarkin
Overview
Explore the profile of Paul E Croarkin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
208
Citations
1851
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Wilton A, Saliba C, Marrero-Polanco J, Sheffield K, Wilkes Q, Anacker M, et al.
Clin Transl Sci
. 2025 Feb;
18(2):e70155.
PMID: 39954233
Adherence in digital health studies with extended observation periods (≥ 12 months) is limited, and participant retention considerably reduces with time. The US Food and Drug Administration has issued guidelines...
3.
Brunoni A, Croarkin P, Razza L
Biomedicines
. 2025 Jan;
13(1.
PMID: 39857598
In the Sustainable Development Goals of the United Nations for 2030, mental health has been identified as a global priority, emphasizing the need to reduce the prevalence, morbidity, and premature...
4.
Ren C, Kung S, Croarkin P, Opitz A, Forester B, Hermida A, et al.
J ECT
. 2025 Jan;
PMID: 39853304
Electroconvulsive therapy (ECT) is an effective treatment for severe depression, especially in treatment-resistant cases. However, its potential cognitive side effects necessitate careful dosing to balance therapeutic benefits and cognitive stability....
5.
Semaan F, Croarkin P
J Psychiatr Pract
. 2025 Jan;
31(1):20-23.
PMID: 39836677
Borderline personality disorder (BPD) poses significant challenges for early identification and diagnosis due to its intricate symptomatology that overlaps with other psychiatric illnesses. To address this challenge, the McLean Screening...
6.
Alshafei R, Croarkin P, McVoy M
J Child Adolesc Psychopharmacol
. 2025 Jan;
35(2):67-68.
PMID: 39818962
No abstract available.
7.
Leffler J, Azzopardi D, Jensen P, Croarkin P, Cullen K, Duffy A, et al.
Child Psychiatry Hum Dev
. 2025 Jan;
PMID: 39786681
The diagnosis of bipolar disorder (BD) in young children has been a topic of debate, in part owing to varied interpretation of manic-like symptoms. We examined how expert academic clinicians...
8.
Sutherland I, Ho M, Croarkin P
J Child Adolesc Psychopharmacol
. 2025 Jan;
PMID: 39761065
Interest in psychedelic therapies for adults is rapidly growing, with substances like 3,4-methylenedioxymethamphetamine for posttraumatic stress disorder, psilocybin for treatment-resistant depression, and lysergic acid diethylamide for generalized anxiety disorder showing...
9.
Garzon J, Elmaadawi A, Aaronson S, Schrodt Jr G, Holbert R, Zuckerman S, et al.
J Child Adolesc Psychopharmacol
. 2024 Dec;
35(2):99-108.
PMID: 39718805
Transcranial magnetic stimulation (TMS) is a promising intervention for adolescents with treatment-resistant depression (TRD). However, the durability of TMS-related improvement in adolescents is unclear. This 6-month study followed adolescents with...
10.
Croarkin P, Sutherland I, Ho M
J Am Acad Child Adolesc Psychiatry
. 2024 Dec;
PMID: 39709009
We read with great interest the commentary by Jeffrey et al. entitled "Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With Caution." We...